Responses
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients
Compose a Response to This Article
Other responses
No responses have been published for this article.